Anna M. Czarnecka

6.2k total citations
232 papers, 4.0k citations indexed

About

Anna M. Czarnecka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anna M. Czarnecka has authored 232 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 95 papers in Pulmonary and Respiratory Medicine and 89 papers in Molecular Biology. Recurrent topics in Anna M. Czarnecka's work include Sarcoma Diagnosis and Treatment (49 papers), Renal cell carcinoma treatment (35 papers) and Renal and related cancers (31 papers). Anna M. Czarnecka is often cited by papers focused on Sarcoma Diagnosis and Treatment (49 papers), Renal cell carcinoma treatment (35 papers) and Renal and related cancers (31 papers). Anna M. Czarnecka collaborates with scholars based in Poland, United States and Italy. Anna M. Czarnecka's co-authors include Cezary Szczylik, Ewa Bartnik, Piotr Rutkowski, Michał Fiedorowicz, Camillo Porta, Zofia F. Bielecka, Fei Lian, Paweł Sobczuk, Wojciech Kukwa and Klaudia Brodaczewska and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anna M. Czarnecka

215 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna M. Czarnecka Poland 33 2.0k 1.3k 1.2k 928 319 232 4.0k
Xianglin Yuan China 36 2.3k 1.2× 1.2k 1.0× 1.1k 0.9× 1.0k 1.1× 633 2.0× 233 5.0k
Xiaoping Zhang China 39 3.5k 1.7× 969 0.8× 1.3k 1.1× 1.9k 2.0× 380 1.2× 231 6.0k
Jessica Wang‐Rodriguez United States 34 2.0k 1.0× 959 0.7× 634 0.5× 894 1.0× 284 0.9× 96 3.9k
Anne E. Cress United States 41 2.8k 1.4× 1.8k 1.4× 924 0.8× 931 1.0× 464 1.5× 147 5.4k
Subodh M. Lele United States 41 1.8k 0.9× 1.1k 0.9× 652 0.5× 623 0.7× 460 1.4× 128 4.2k
Boe Sandahl Sørensen Denmark 37 2.7k 1.4× 2.0k 1.6× 1.3k 1.1× 1.6k 1.7× 380 1.2× 171 4.9k
Ronald Rodríguez United States 36 2.8k 1.4× 1.1k 0.8× 1.5k 1.2× 520 0.6× 365 1.1× 153 4.7k
Lisa M. Butler Australia 41 4.0k 2.0× 1.6k 1.2× 1.8k 1.5× 2.1k 2.3× 383 1.2× 149 6.7k
Ying Yang China 41 2.2k 1.1× 1.7k 1.3× 868 0.7× 1.3k 1.4× 502 1.6× 136 5.1k
Shakeel Modak United States 37 1.7k 0.8× 1.5k 1.2× 827 0.7× 869 0.9× 758 2.4× 160 4.7k

Countries citing papers authored by Anna M. Czarnecka

Since Specialization
Citations

This map shows the geographic impact of Anna M. Czarnecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Czarnecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Czarnecka more than expected).

Fields of papers citing papers by Anna M. Czarnecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Czarnecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Czarnecka. The network helps show where Anna M. Czarnecka may publish in the future.

Co-authorship network of co-authors of Anna M. Czarnecka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Czarnecka. A scholar is included among the top collaborators of Anna M. Czarnecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Czarnecka. Anna M. Czarnecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ciążyńska, Magdalena, et al.. (2025). Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It. Biomolecules. 15(2). 269–269. 10 indexed citations
3.
Rutkowski, Piotr, et al.. (2025). Selinexor in the treatment of liposarcoma: from preclinical evidence to clinical practice. Medical Oncology. 42(4). 94–94.
4.
Czarnecka, Anna M., et al.. (2024). Distal and proximal epithelioid sarcoma — differences in diagnosis and similarities in treatment. Oncology in Clinical Practice. 21(1). 60–70. 1 indexed citations
5.
Czarnecka, Anna M., Anna Szumera‐Ciećkiewicz, Tomasz Świtaj, et al.. (2024). Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma. Cancer. 130(20). 3463–3472. 1 indexed citations
6.
Świtaj, Tomasz, Mateusz Spałek, Joanna Radzikowska, et al.. (2023). Diagnosis and treatment of rhabdomyosarcomas. Oncology in Clinical Practice. 19(4). 250–279. 2 indexed citations
7.
Rutkowski, Piotr, Anna Szumera‐Ciećkiewicz, Agnieszka Zając, et al.. (2023). 1969P Intratumoral immune infiltrates in chondrosarcoma (ChS). Annals of Oncology. 34. S1052–S1052. 2 indexed citations
8.
Szumera‐Ciećkiewicz, Anna, Mateusz Spałek, Michał Wągrodzki, et al.. (2023). Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas. Cancers. 15(11). 2960–2960. 5 indexed citations
9.
Radzikowska, Joanna, Anna M. Czarnecka, Anna Raciborska, et al.. (2022). Cancer Stem Cell Markers in Rhabdomyosarcoma in Children. Diagnostics. 12(8). 1895–1895. 3 indexed citations
10.
Sobczuk, Paweł, Katarzyna Kozak, Tomasz Świtaj, et al.. (2022). Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study. Cancers. 14(2). 422–422. 3 indexed citations
11.
Czarnecka, Anna M., Paweł Sobczuk, Tomasz Świtaj, et al.. (2022). Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence. Cancer Immunology Immunotherapy. 71(8). 1949–1958. 13 indexed citations
12.
Cybulska-Stopa, Bożena, Marcin Ziętek, Anna M. Czarnecka, et al.. (2021). Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. Journal of Dermatological Treatment. 33(4). 2168–2174. 8 indexed citations
13.
Zając, Agnieszka, Mateusz Spałek, Michał Fiedorowicz, et al.. (2021). Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers. 13(10). 2390–2390. 49 indexed citations
14.
Teterycz, Paweł, Anna M. Czarnecka, Alice Indini, et al.. (2020). Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy. Cancers. 12(11). 3131–3131. 25 indexed citations
15.
Szymański, Łukasz, Michał Fiedorowicz, Ewa Bartnik, et al.. (2019). Komórki macierzyste raka nerki – Pochodzenie i znaczenie. Postępy Biochemii. 65(2). 95–102. 3 indexed citations
16.
Radzikowska, Joanna, Wojciech Kukwa, Andrzej Kukwa, et al.. (2016). Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients. Oncology Letters. 12(5). 3555–3562. 18 indexed citations
17.
Szymański, Łukasz, et al.. (2016). Thyroid Hormones as Renal Cell Cancer Regulators. SHILAP Revista de lepidopterología. 2016. 1–8. 10 indexed citations
18.
Czarnecka, Anna M., Łukasz Szymański, Fei Lian, et al.. (2015). The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis. Stem Cell Reviews and Reports. 11(6). 919–943. 74 indexed citations
19.
Czarnecka, Anna M., Paweł Sobczuk, Fei Lian, & Cezary Szczylik. (2014). Renal cell carcinoma with intramyocardial metastases. BMC Urology. 14(1). 73–73. 10 indexed citations
20.
Czarnecka, Anna M., Paweł Golik, & Ewa Bartnik. (2006). Mitochondria jako integratory apoptozy. Postepy Biologii Komorki. 33(3). 525–541. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026